Fingerprint
Dive into the research topics where Ross McMullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Physiologic determinants of near-infrared spectroscopy-derived cerebral and tissue oxygen saturation measurements in critically ill patients
Cody, N., Bradbury, I., McMullan, R. R., Quinn, G., O’Neill, A., Ward, K., McCann, J., McAuley, D. F. & Silversides, J. A., May 2024, In: Critical Care Explorations. 6, 5, 9 p., e1094.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Link opens in a new tab Citations (Scopus)82 Downloads (Pure) -
Vascular leak in sepsis: physiological basis and potential therapeutic advances
McMullan, R. R., McAuley, D. F., O'Kane, C. M. & Silversides, J. A., 23 Mar 2024, In: Critical Care. 28, 15 p., 97.Research output: Contribution to journal › Review article › peer-review
Open AccessFile81 Link opens in a new tab Citations (Scopus)341 Downloads (Pure) -
Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the role of active deresuscitation after resuscitation-2 (RADAR-2) randomised clinical trial
Silversides, J. A., McMullan, R., Emerson, L. M., Bradbury, I., Bannard-Smith, J., Szakmany, T., Trinder, J., Rostron, A. J., Johnston, P., Ferguson, A. J., Boyle, A. J., Blackwood, B., Marshall, J. C. & McAuley, D. F., Nov 2023, In: Intensive Care Medicine. 49, p. 1440 1 p.Research output: Contribution to journal › Comment/debate
2 Link opens in a new tab Citations (Scopus) -
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia
Greenfield, G., McMullan, R., Robson, N., McGimpsey, J., Catherwood, M. & McMullin, M. F., 02 May 2019, In: EMJ Hematology. 19, p. 7Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Link opens in a new tab Citations (Scopus)201 Downloads (Pure) -
Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients
McMullan, R. R., McConville, C. & McMullin, M. F., May 2019, In: The Ulster Medical Journal. 88, 2, p. 105-110 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Link opens in a new tab Citations (Scopus)120 Downloads (Pure)